TRF2 preserves muscle stem cells’ ability to regenerate tissue
- TRF2 helps maintain the identity of muscle stem cells and their ability to repair tissue.
- In mice lacking TRF2, damaged muscle was gradually replaced by fatty and scar tissue.
- In a model of Duchenne muscular dystrophy, removing TRF2 accelerated degeneration and shortened the animals’ lifespan.
An unexpected function of a protein known for protecting chromosomes
Researchers at the Perelman School of Medicine at the University of Pennsylvania found that the protein TRF2 is needed for more than just protecting chromosomes. It also helps preserve the properties of muscle stem cells—the cells responsible for tissue repair after injury. The findings were published in the journal Science Advances. The authors believe the discovery could point to new directions for studying muscle diseases, but it does not in itself mean that a treatment is on the way.
Normally, muscle stem cells remain inactive most of the time. After an injury, they activate, multiply, and help replace damaged muscle tissue. Some cells then return to a resting state, preserving a reserve for future injuries. That is why it is important not only that cells can divide during recovery, but also that the population is preserved so it can repeat this cycle later.
TRF2 has previously been studied primarily as a protein that protects telomeres—structures at the ends of chromosomes that help shield them from degradation and from being mistakenly recognized as damaged DNA. The new study adds another role to this known function: maintaining the genetic instructions that determine the identity of muscle stem cells. In laboratory experiments, TRF2 levels changed as cells shifted between dormancy, recovery, and replenishment of the reserve.
Loss of Cellular Identity Disrupts Muscle Repair
To find out what happens without TRF2, scientists removed this protein from the muscle stem cells of laboratory mice. At first, the animals’ muscles looked normal: the researchers observed no immediate damage to existing tissue. Over time, however, the number of functional stem cells declined. As a result, the muscles’ ability to respond to injury gradually weakened, even though the tissues’ initial appearance gave no sign of an obvious problem.
The researchers expected cells deprived of TRF2 to die: in other tissues, the loss of this protein can lead to that outcome. But muscle stem cells showed a different pattern. The cells remained alive, yet lost the molecular features they needed to perform their specialized role. In other words, the problem was not simply cell death, but the loss of the biological program that enables them to recognize and repair muscle tissue.
The effects became apparent after muscle damage. Instead of healthy tissue being restored, fat and scar tissue accumulated in its place. This replacement does not restore normal muscle function, so the loss of stem cell identity is linked to a severe decline in recovery. The study’s senior author, Fotini Mourkioti, noted that this finding changes how we understand the role of TRF2: the loss of cellular identity may call into question whether recovery from injury is possible at all.
The role of TRF2 in a model of Duchenne muscular dystrophy
The team also examined the importance of TRF2 in a model of Duchenne muscular dystrophy—a severe inherited disease in which muscles gradually weaken and break down. Maintaining healthy muscle tissue and repairing it are especially important for people with this disease. In the mouse model, removing TRF2 from muscle stem cells was accompanied by a sharp worsening of the condition: degeneration progressed faster, and the affected animals’ lifespans were shortened.
These results indicate that TRF2 helps preserve the regenerative potential of muscles already under strain from an inherited disease. But the study does not prove that the protein can be used as a ready-made treatment for Duchenne muscular dystrophy. The authors point to a possible direction for further research: investigating whether it is possible to target the identified mechanism and thereby support stem cell function. The results presented do not establish the effectiveness of this approach as a treatment.
It is also important to consider the limits of the investigation: the described experiments involving TRF2 deletion were conducted in mice, including a disease model. They show the effects of losing the protein under these conditions, but do not indicate that a similar method has already been tested as a treatment in humans. Nor has it been established whether TRF2 levels or activity can be safely manipulated to restore tissue. Therefore, the practical outcome of the study for now is the discovery of a biological mechanism, not a clinical recommendation.
Link to gene regulation and questions for future research
To understand how the protein might perform this function, researchers studied its interaction with the genome. In addition to acting at chromosome ends, TRF2 binds to regulatory regions in different parts of the genome. These regions help control which genes are active and which are switched off, thereby influencing cell behavior. Muscle stem cells require a distinct pattern of gene activity that maintains their identity and ability to regenerate.
Many DNA regions associated with TRF2 contain structures called G-quadruplexes. They form in guanine-rich regions when DNA folds into an unusual configuration involving four interacting strands or segments. These structures have attracted scientists’ attention because they may affect gene activity. They are also being studied as potential targets for cancer therapy. However, the account of the work presented here does not report testing this approach in patients.
The observations also raise a broader question: how to reconcile the regenerative capacity of skeletal muscle with the relative rarity of cancers originating in muscle tissue. The authors believe that studying TRF2 may help investigate the differences between muscle repair and cancer development. But the results do not yet explain this difference or show that the mechanism they identified prevents tumors. Further research will be needed to draw such a conclusion; for now, TRF2 has been shown to play a role in maintaining muscle stem cells.
Source: ScienceDaily
